11 Pulmonary Embolism Clinical Trials in Hartford, CT (2026)

Q: How do I join a clinical trial in Hartford?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Hartford research site will contact you.

Recruiting Pulmonary Embolism Studies in Hartford

NCT06087029Recruiting

IMPRoving Outcomes in Vascular DisEase - Aortic Dissection

The goal of this clinical trial is to determine whether an upfront invasive strategy of TEVAR plus medical therapy reduces the occurrence of a composite endpoint of all-cause death or major aortic com...

Hartford, CTNA1,100 participantsDuke University

View Study Details

NCT04629014Recruiting

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using dat...

Hartford, CT750 participantsBoston Children's Hospital

View Study Details

NCT03911700Recruiting

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hern...

Hartford, CTNA477 participantsC. R. Bard

View Study Details

NCT06740383Recruiting

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

The Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizophrenia, Schizoaffective Disorder, and Bi...

Hartford, CT320 participantsBeth Israel Deaconess Medical Center

View Study Details

NCT05180773Recruiting

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of bromocriptine therapy to evaluate its impact on my...

Hartford, CTPHASE4250 participantsDennis M. McNamara, MD, MS

View Study Details

NCT03546374Recruiting

Medtronic Terminate AF Study

The purpose of this study is to demonstrate the safety and effectiveness of the Cardioblate iRF and CryoFlex hand held devices for the treatment of non-paroxysmal atrial fibrillation (AF)....

Hartford, CTNA160 participantsMedtronic Cardiac Surgery

View Study Details

NCT06672510Recruiting

Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)

This study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the Akura Thrombectomy System in subje...

Hartford, CTNA118 participantsAkura Medical

View Study Details

NCT06129240Recruiting

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 \& 3 PH....

Hartford, CT80 participantsLiquidia Technologies, Inc.

View Study Details

NCT07238556Recruiting

A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

The investigators will conduct a feasibility and pilot efficacy randomized controlled trial to test the usability and user satisfaction of an evidence-based digital health tool the investigators devel...

Hartford, CTNA72 participantsUniversity of Connecticut

View Study Details

NCT06982066Recruiting

Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention

The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to im...

Hartford, CTNA60 participantsConnecticut Children's Medical Center

View Study Details

NCT06843330Recruiting

Accuracy of Lactate Meter in GSDIa

The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, compared to lab serum lactate in a population of patients with glycogen stor...

Hartford, CT10 participantsConnecticut Children's Medical Center

View Study Details

About Pulmonary Embolism Clinical Trials in Hartford

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 11 pulmonary embolism clinical trials recruiting participants in Hartford, CT. These studies are seeking a combined 3,397 participants. Research is being sponsored by Duke University, Boston Children's Hospital, C. R. Bard and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Hartford — FAQ

Are there pulmonary embolism clinical trials in Hartford?

Yes, there are 11 pulmonary embolism clinical trials currently recruiting in Hartford, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Hartford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hartford research site will contact you about next steps.

Are clinical trials in Hartford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hartford studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 11 active trials in Hartford are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 18, 2026 from ClinicalTrials.gov